KP Tissue Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	2.43	-4.94	-10.25	1.24	-1.95	Upgrade
Loss (Gain) From Sale of Investments	0.5	0.13	4.46	5	-0.63	Upgrade
Loss (Gain) on Equity Investments	-2.99	0.7	8.09	-6.13	1.43	Upgrade
Other Operating Activities	0.65	3.82	-2.22	-0.35	1.01	Upgrade
Change in Accounts Receivable	-	-	-	0.02	0.15	Upgrade
Change in Accounts Payable	-0.6	0.29	-0.08	0.21	-	Upgrade
Investment in Securities	-	-	6.62	5.56	5.6	Upgrade
Other Investing Activities	6.97	6.98	-	-	-	Upgrade
Investing Cash Flow	6.97	6.98	6.62	5.56	5.6	Upgrade
Common Dividends Paid	-6.97	-6.98	-6.62	-5.56	-5.6	Upgrade
Financing Cash Flow	-6.97	-6.98	-6.62	-5.56	-5.6	Upgrade
Cash Income Tax Paid	-0.6	0.29	-0.08	2.28	1.02	Upgrade
Change in Net Working Capital	-0.2	-0.22	2.46	0.52	-1.8	Upgrade

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.